Gerald D. LaVeck

1.2k total citations
21 papers, 893 citations indexed

About

Gerald D. LaVeck is a scholar working on Infectious Diseases, Endocrinology and Psychiatry and Mental health. According to data from OpenAlex, Gerald D. LaVeck has authored 21 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Endocrinology and 4 papers in Psychiatry and Mental health. Recurrent topics in Gerald D. LaVeck's work include Escherichia coli research studies (6 papers), Viral gastroenteritis research and epidemiology (4 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Gerald D. LaVeck is often cited by papers focused on Escherichia coli research studies (6 papers), Viral gastroenteritis research and epidemiology (4 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Gerald D. LaVeck collaborates with scholars based in United States. Gerald D. LaVeck's co-authors include Alison D. O’Brien, Michael R. Thompson, Samuel B. Formal, R. T. Ravenholt, D E Griffin, Felix F. de la Cruz, Felix de la Cruz, David B. Thomas, Dean L. Mann and John D. Groopman and has published in prestigious journals such as New England Journal of Medicine, Neurology and PEDIATRICS.

In The Last Decade

Gerald D. LaVeck

20 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald D. LaVeck United States 13 590 498 113 112 111 21 893
Jakob Frimodt-Møller Denmark 17 346 0.6× 285 0.6× 61 0.5× 88 0.8× 110 1.0× 32 865
E. J. Gangarosa United States 13 480 0.8× 446 0.9× 80 0.7× 31 0.3× 235 2.1× 24 762
N. J. Richardson South Africa 16 74 0.1× 221 0.4× 30 0.3× 108 1.0× 490 4.4× 26 829
Oscar Felsenfeld United States 14 247 0.4× 146 0.3× 117 1.0× 14 0.1× 69 0.6× 101 705
Heather Kent Canada 7 117 0.2× 83 0.2× 54 0.5× 61 0.5× 231 2.1× 40 578
Yankel M. Kupersztoch United States 13 231 0.4× 86 0.2× 15 0.1× 121 1.1× 62 0.6× 17 480
Kaori Izutsu Japan 11 334 0.6× 116 0.2× 218 1.9× 106 0.9× 173 1.6× 12 850
Ruth E. Luna‐Gierke United States 9 191 0.3× 262 0.5× 56 0.5× 40 0.4× 111 1.0× 14 436
Pascale Vonaesch Switzerland 14 226 0.4× 189 0.4× 68 0.6× 88 0.8× 168 1.5× 38 901
Shu‐ichi Nakayama Japan 21 160 0.3× 113 0.2× 54 0.5× 73 0.7× 79 0.7× 54 1.9k

Countries citing papers authored by Gerald D. LaVeck

Since Specialization
Citations

This map shows the geographic impact of Gerald D. LaVeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald D. LaVeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald D. LaVeck more than expected).

Fields of papers citing papers by Gerald D. LaVeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald D. LaVeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald D. LaVeck. The network helps show where Gerald D. LaVeck may publish in the future.

Co-authorship network of co-authors of Gerald D. LaVeck

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald D. LaVeck. A scholar is included among the top collaborators of Gerald D. LaVeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald D. LaVeck. Gerald D. LaVeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boethling, Robert S., et al.. (1988). Validation of CHEMEST, an on-line system for the estimation of chemical properties. Ecotoxicology and Environmental Safety. 15(1). 21–30. 8 indexed citations
2.
Harris, Curtis C., Gerald D. LaVeck, John D. Groopman, Vincent L. Wilson, & Dean L. Mann. (1986). Measurement of aflatoxin B1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry.. PubMed. 46(7). 3249–53. 18 indexed citations
3.
Hammond, Mary A., et al.. (1983). Further Observations on Minor Anomalies and Behavior in Different Home Environments. Journal of Pediatric Psychology. 8(2). 171–179. 2 indexed citations
4.
O’Brien, Alison D. & Gerald D. LaVeck. (1982). Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins. Infection and Immunity. 35(3). 1151–1154. 48 indexed citations
5.
O’Brien, Alison D., Gerald D. LaVeck, Michael R. Thompson, & Samuel B. Formal. (1982). Production of Shigella dysenteriae Type 1-Like Cytotoxin by Escherichia coli. The Journal of Infectious Diseases. 146(6). 763–769. 323 indexed citations
6.
Hammond, Mary A., et al.. (1980). Minor congenital anomalies and behavior in different home environments. The Journal of Pediatrics. 96(5). 940–943. 1 indexed citations
7.
O’Brien, Alison D., Gerald D. LaVeck, D E Griffin, & Michael R. Thompson. (1980). Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infection and Immunity. 30(1). 170–179. 76 indexed citations
8.
Cruz, Felix F. de la, et al.. (1974). Human Sexuality and the Mentally Retarded. The Family Coordinator. 23(1). 98–98. 49 indexed citations
9.
LaVeck, Gerald D.. (1965). Medical Aspects of Mental Retardation. PEDIATRICS. 35(6). 1031–1031. 15 indexed citations
10.
LaVeck, Gerald D., et al.. (1963). Shigellosis: Mass Drug Therapy in an Institutional Setting. American Journal of Public Health and the Nations Health. 53(2). 266–273. 8 indexed citations
11.
LaVeck, Gerald D. & Felix de la Cruz. (1963). ELECTROENCEPHALOGRAPHIC AND ETIOLOGIC FINDINGS IN MENTAL RETARDATION. PEDIATRICS. 31(3). 478–485. 4 indexed citations
12.
LaVeck, Gerald D., Felix de la Cruz, & David B. Thomas. (1962). Anticonvulsant Properties of Amino‐Oxyacetic Acid: Clinical Studies. The Journal of New Drugs. 2(3). 160–166. 2 indexed citations
13.
LaVeck, Gerald D., Felix de la Cruz, & David B. Thomas. (1962). Clinical evaluation of a new anticonvulsant, sulthiame. Neurology. 12(12). 923–923. 12 indexed citations
14.
LaVeck, Gerald D., et al.. (1961). The use of psychopharmacologic agents in retarded children with behavior disorders. Journal of Chronic Diseases. 13(2). 174–183. 14 indexed citations
15.
LaVeck, Gerald D., et al.. (1960). Sulfadimethoxine in the treatment and prevention of epidemic shigellosis.. PubMed. 7. 119–24. 2 indexed citations
16.
LaVeck, Gerald D., et al.. (1958). METACHROMATIC LEUKO-ENCEPHALOPATHY. PEDIATRICS. 22(6). 1064–1073. 13 indexed citations
17.
LaVeck, Gerald D., et al.. (1957). Staphylococcal Infections in an Obstetric Unit. New England Journal of Medicine. 257(7). 295–303. 53 indexed citations
18.
LaVeck, Gerald D., et al.. (1957). Staphylococcal Infections in an Obstetric Unit. New England Journal of Medicine. 257(7). 304–306. 15 indexed citations
19.
Ravenholt, R. T. & Gerald D. LaVeck. (1956). Staphylococcal Disease—An Obstetric, Pediatric, and Community Problem. American Journal of Public Health and the Nations Health. 46(10). 1287–1296. 38 indexed citations
20.
LaVeck, Gerald D., et al.. (1955). Inapparent Infection with Western Equine Encephalitis Virus: Epidemiologic Observations. American Journal of Public Health and the Nations Health. 45(11). 1409–1416. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026